Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

KYTX US Equity

Kyverna Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1994702 · FY ends Dec 31
$8.87
+0.37 (+4.35%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Bain Capital Life Sciences Opportunities III, LPsec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-278-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-278-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-098-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-09

Every row is a filed document, checked against its EDGAR index.